Therapeutic Classification: anti-Alzheimers's agents
Pharmacologic Classification: n methyl d aspartate antagonist
Absorption: Well absorbed after oral administration.
Distribution: Unknown.
Metabolism/Excretion: 57–82% excreted unchanged in urine by active tubular secretion moderated by pH dependent tubular reabsorption. Remainder metabolized; metabolites are not pharmacologically active.
Half-Life: 60–80 hr.
